# Cochlear Implants in Menière’s Disease

[](<warning: Undefined array key 0 in /code/wp-content/themes/hear-better/template-parts/hero/hero.php on line 71>)

 [hearbetter](https://hearbetter.medel.com/en-int/) &gt; Cochlear Implants in Menière’s Disease 

 [    Back ](javascript:history.back()) 

     

 

#  Cochlear Implants in Menière’s Disease 

 

 ## **SCIENCE UPDATE**

*New scientific studies summarized for you*

### **Cochlear Implants in Menière’s Disease**

(Original title: *Hearing and Vestibular Outcomes in Patients Undergoing Labyrinthectomy and Cochlear Implant in End-Stage Menière’s Disease”*, 2025, Almashhadani et al.)

### **Key Message**

Simultaneous labyrinthectomy and cochlear implantation (CI) is an effective treatment for patients with end-stage Menière’s disease (MD), offering significant improvements in hearing, vertigo control, and tinnitus, especially in younger patients.

### **Background**

In advanced stages of Menière’s disease, patients may experience profound hearing loss and intractable vertigo. While labyrinthectomy effectively controls vertigo, it sacrifices residual hearing. Cochlear implantation offers a solution for hearing restoration. This study investigates the combined approach of labyrinthectomy and CI, performed either simultaneously or sequentially, as a comprehensive treatment for end-stage MD.

- ### **Method**

– Retrospective study
– 39 patients treated between 2014 and 2023
Mean age: 59.3 years;
24 patients &lt;65 years
15 patients &gt;65 years

Severe-profound hearing loss

Intractable vertigo

Unilateral (22 patients) or bilateral MD (10 pt) or secondary menieriform disorders (7 pt)

Average follow-up duration: 28 months

- ### **Evaluation**

– Pure Tone Audiometry (PTA) and Speech Discrimination Scores (SDS) for hearing
– Dizziness Handicap Inventory (DHI) for vertigo
– Tinnitus Handicap Inventory (THI) for tinnitus
– Subgroup analyses were conducted based on age (&lt;65 vs. ≥65) and MD type (unilateral, bilateral, or secondary).

- **Results Hearing**

**–** Significant improvement in PTA
– SDS improved overall, especially in younger patients and those with bilateral MD
– Patients with contralateral hearing aids showed enhanced binaural benefits**Vertigo
–** DHI scores improved significantly
– 54% of patients experienced complete resolution of vertigo
– Older patients (≥65) showed less vestibular compensation

- **Tinnitus**

– THI scores dropped significantly
– Most patients reported subjective tinnitus relief when the CI was active

- **Safety**

– No adverse surgical outcomes were reported
– Simultaneous procedures reduced surgical burden and risk of cochlear ossification

### **Conclusion**

Simultaneous labyrinthectomy and cochlear implantation is an effective approach for managing both hearing loss and vertigo in patients with end-stage Menière’s disease, offering significant benefits in hearing restoration, tinnitus suppression, and vertigo control. Careful patient selection and counselling are essential.

(Read the full paper here: [Otology &amp; Neurotology](https://journals.lww.com/otology-neurotology/fulltext/2025/10000/hearing_and_vestibular_outcomes_in_patients.12.aspx))

 

 

##  Stay ahead in cochlear implant innovation 

 Subscribe for peer-reviewed updates, case studies, and the latest developments in hearing restoration technology from leading medical professionals.

   Subscribe  

 Information about MED-EL's privacy policy can be found [here](https://hearbetter.medel.com/en-int/privacy-policy/). 

  A valid email is required.